StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Aspira Women's Health's revenue for the twelve months ending Jun 30, 2026 was $170.00K. For fiscal 2025 it was $343.00K, up 8475.0% from the year before. Over ten years it grew -16.9% a year on average. The highest annual figure on record is $87.00M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$343.00K+8475.0%
FY2024Dec 31, 2024$4.00K-100.0%
FY2023Dec 31, 2023$87.00M+963.0%
FY2022Dec 31, 2022$8.18M+20.1%
FY2021Dec 31, 2021$6.81M+46.5%
FY2020Dec 31, 2020$4.65M+2.5%
FY2019Dec 31, 2019$4.54M+48.6%
FY2018Dec 31, 2018$3.05M-2.2%
FY2017Dec 31, 2017$3.12M+18.1%
FY2016Dec 31, 2016$2.64M+21.4%
FY2015Dec 31, 2015$2.18M-13.6%
FY2014Dec 31, 2014$2.52M-1.8%
FY2013Dec 31, 2013$2.57M+22.5%
FY2012Dec 31, 2012$2.09M+8.9%
FY2011Dec 31, 2011$1.92M+63.7%
FY2010Dec 31, 2010$1.18M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.00K-89.9%
Q1 FY2026Mar 31, 2026$32.00K–
Q4 FY2025Dec 31, 2025$32.00K-98.6%
Q3 FY2025Sep 30, 2025$89.00K-96.3%
Q2 FY2025Jun 30, 2025$169.00K-92.2%
Q1 FY2025Mar 31, 2025$0-100.0%
Q3 FY2024Sep 30, 2024$2.26M+1.8%
Q2 FY2024Jun 30, 2024$2.42M-2.7%
Q1 FY2024Mar 31, 2024$2.15M-7.0%
Q4 FY2023Dec 31, 2023$79.98M+3614.6%
Q3 FY2023Sep 30, 2023$2.22M+7.0%
Q2 FY2023Jun 30, 2023$2.49M+20.6%
Q1 FY2023Mar 31, 2023$2.32M+22.3%
Q4 FY2022Dec 31, 2022$2.15M+16.3%
Q3 FY2022Sep 30, 2022$2.07M+24.4%
Q2 FY2022Jun 30, 2022$2.07M+14.8%
Q1 FY2022Mar 31, 2022$1.89M+26.5%
Q4 FY2021Dec 31, 2021$1.85M+28.0%
Q3 FY2021Sep 30, 2021$1.67M+34.5%
Q2 FY2021Jun 30, 2021$1.80M+141.2%
Q1 FY2021Mar 31, 2021$1.50M+22.6%
Q4 FY2020Dec 31, 2020$1.45M+10.6%
Q3 FY2020Sep 30, 2020$1.24M-3.6%
Q2 FY2020Jun 30, 2020$746.00K-34.7%
Q1 FY2020Mar 31, 2020$1.22M+51.9%
Q4 FY2019Dec 31, 2019$1.31M+41.9%
Q3 FY2019Sep 30, 2019$1.29M+66.0%
Q2 FY2019Jun 30, 2019$1.14M+61.3%
Q1 FY2019Mar 31, 2019$803.00K+23.7%
Q4 FY2018Dec 31, 2018$922.00K+15.5%
Q3 FY2018Sep 30, 2018$774.00K+10.7%
Q2 FY2018Jun 30, 2018$708.00K-21.2%
Q1 FY2018Mar 31, 2018$649.00K-10.6%
Q4 FY2017Dec 31, 2017$798.00K-0.9%
Q3 FY2017Sep 30, 2017$699.00K+12.2%
Q2 FY2017Jun 30, 2017$898.00K–
Q1 FY2017Mar 31, 2017$726.00K–
Q4 FY2016Dec 31, 2016$805.00K–
Q3 FY2016Sep 30, 2016$623.00K–

More Aspira Women's Health figures

See a number that looks wrong?